Diagnostic Yield of Rapid Whole Genome Sequencing in Hospitalized Adults with Unexplained Neurological Manifestations
Manouchehr Amanat1, Michel Toledano1, Lisa Schimmenti1, Pavel Pichurin1, David Deyle1, Ethylin Jabs1, Radhika Dhamija1
1Mayo Clinic
Objective:

To evaluate the diagnostic yield and clinical relevance of rapid whole genome sequencing (rWGS) in hospitalized adults with unexplained neurological manifestations.

Background:

Unexplained neurological presentations in adults often pose diagnostic challenges, leading to prolonged hospitalizations and uncertainty in clinical management. rWGS has emerged as a powerful diagnostic tool to uncover underlying genetic etiologies; however, data on its diagnostic yield in adult inpatient neurology populations remain limited.

Design/Methods:

We conducted a retrospective review of hospitalized adult patients (≥18 years) with neurological symptoms and prolonged stays who underwent rWGS between June 2022 and September 2025 at Mayo Clinic. rWGS was offered when the primary team suspected a genetic etiology contributing to the patient’s complex and unexplained neurological manifestations. Demographic data, sequencing results, variant classifications, and genotype–phenotype correlations were reviewed and analyzed.

Results:
Among 96 hospitalized individuals who underwent rWGS, 58 patients (20 females, 38 males) presented with neurological manifestations and were included in this analysis. The mean (SD) age was 53 (18) years. All patients presented with complex, multifocal neurological manifestations, with ataxia (27%) and epilepsy (20%) being the most common features. Following detailed phenotype evaluation, 14 individuals (24%) were found to have variants consistent with their clinical presentation. Of these, 10 patients carried pathogenic or likely pathogenic variants, and 4 had variants of uncertain significance (VUS) that upon reverse phenotyping were determined to explain the clinical manifestations. All 14 patients had a monogenic disorder.
Conclusions:

In hospitalized adults with unexplained neurological manifestations, rWGS provided a definitive or likely genetic diagnosis in approximately one-quarter of cases. These findings underscore the clinical utility of rWGS in adult neurology, highlighting its potential to expedite diagnosis, guide management, shorten hospital stays, and inform family counseling.

10.1212/WNL.0000000000215387
Disclaimer: Abstracts were not reviewed by Neurology® and do not reflect the views of Neurology® editors or staff.